SODIUM LAURILSULFATE, Canoderm 5 % kräm, Aqua ad iniectabilia Braun Lösungsmittel zur Herstellung von Parenteralia, Propyless 200 mg/g kutan emulsion, Miniderm 20 % kräm, CARBAMIDE, COMBINATIONS
CSCI-SKT-B1001
Phase 2 small_molecule active
Quick answer
SODIUM LAURILSULFATE, Canoderm 5 % kräm, Aqua ad iniectabilia Braun Lösungsmittel zur Herstellung von Parenteralia, Propyless 200 mg/g kutan emulsion, Miniderm 20 % kräm, CARBAMIDE, COMBINATIONS for Atopic dermatitis is a Phase 2 program (small_molecule) at Nordic Group B.V. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Nordic Group B.V.
- Indication
- Atopic dermatitis
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active